Animal and translational models of SARS-CoV-2 infection and COVID-19

Johansen, M. D.; Irving, A.; Montagutelli, X.; Tate, M. D.; Rudloff, I.; Nold, M. F.; Hansbro, N. G.; Kim, R. Y.; Donovan, C.; Liu, G.; Faiz, A.; Short, K. R.; Lyons, J. G.; McCaughan, G. W.; Gorrell, M. D.; Cole, A.; Moreno, C.; Couteur, D.; Hesselson, D.; Triccas, J.; Neely, G. G.; Wark, P. A.; Hansbro, P. M.

Title: Animal and translational models of SARS-CoV-2 infection and COVID-19
Creator: Johansen, M. D.; Irving, A.; Montagutelli, X.; Tate, M. D.; Rudloff, I.; Nold, M. F.; Hansbro, N. G.; Kim, R. Y.; Donovan, C.; Liu, G.; Faiz, A.; Short, K. R.; Lyons, J. G.; McCaughan, G. W.; Gorrell, M. D.; Cole, A.; Moreno, C.; Couteur, D.; Hesselson, D.; Triccas, J.; Neely, G. G.; Wark, P. A.; Hansbro, P. M.
Relation: NHMRC.1175134 http://purl.org/au-research/grants/nhmrc/1175134
Relation: Mucosal Immunology Vol. 13, Issue 6, p. 877-891
Publisher Link: http://dx.doi.org/10.1038/s41385-020-00340-z
Publisher: Nature Publishing Group
Resource Type: journal article
Date: 2020
Description: COVID-19 is causing a major once-in-a-century global pandemic. The scientific and clinical community is in a race to define and develop effective preventions and treatments. The major features of disease are described but clinical trials have been hampered by competing interests, small scale, lack of defined patient cohorts and defined readouts. What is needed now is head-to-head comparison of existing drugs, testing of safety including in the background of predisposing chronic diseases, and the development of new and targeted preventions and treatments. This is most efficiently achieved using representative animal models of primary infection including in the background of chronic disease with validation of findings in primary human cells and tissues. We explore and discuss the diverse animal, cell and tissue models that are being used and developed and collectively recapitulate many critical aspects of disease manifestation in humans to develop and test new preventions and treatments.
Subject: SARS-CoV-2; COVID-19; pandemic; infection prevention; Sustainable Development Goals; SDG 7
Identifier: http://hdl.handle.net/1959.13/1428297
Identifier: uon:38615
Identifier: ISSN:1933-0219
Language: eng
Reviewed

Hits: 9506
Visitors: 9456
Downloads: 0

Collections

Goal 7: Ensure access to affordable, reliable, sustainable and modern energy

		Thumbnail	File	Description	Size	Format